ArticleCancer immunology, immunotherapy : CII2013

MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR.

Carolina M Soto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.